See also this year's filing and all EDGAR filings for this company.
PDF Report 0001641640_2018_Nabriva_Therapeutics_plc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001641640')"} |
Graph
Absolute values for 0001641640, Nabriva Therapeutics plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 93,839,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 172,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,327,000 |
| 3 | remainder_Assets | 425,000 |
| 4 | LiabilitiesCurrent | 13,260,000 |
| 5 | LiabilitiesNoncurrent | 435,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,472,000 |
| 9 | ResearchAndDevelopmentExpense | 49,615,000 |
| 10 | remainder_Expenses | 1,398,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,129,000 |
| 13 | remainder_ComprehensiveNetIncome | 17,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 95,763,000 |
| 1 | Liabilities | 13,695,000 |
| 2 | Expenses | 80,485,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 82,068,000 |
| 5 | NetIncome | -74,356,000 |
| 6 | ComprehensiveNetIncome | -74,347,500 |
| 7 | BaseVar | 98,044,500 |
| 8 | EconomicCapitalRatio | 1.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
